ATROPINE SULFATE INJECTION

ATROPINE SULFATE INJECTION was reported 2533 times

ATROPINE SULFATE INJECTION is most commonly taken among patients reporting these side effects:

# Side effect Count Frequency
0 VAGINAL FLATULENCE 65 0.2145
1 SCHIZENCEPHALY 8 0.1778
2 CEREBRAL HAEMORRHAGE FOETAL 8 0.1311
3 LARGE CELL LUNG CANCER METASTATIC 2 0.1176
4 ANTERIOR SPINAL ARTERY SYNDROME 7 0.0833
5 FEMALE GENITAL TRACT FISTULA 73 0.0427
6 ENZYME INDUCTION 2 0.0417
7 CILIARY HYPERAEMIA 3 0.0316
8 RADICULOPATHY 71 0.0269
9 ANTICHOLINERGIC EFFECT 2 0.0267
10 ANTERIOR CHAMBER FLARE 6 0.0258
11 KERATITIS BACTERIAL 4 0.0245
12 CHRONIC SINUSITIS 87 0.0232
13 PROCTITIS 64 0.0228
14 RHYTHM IDIOVENTRICULAR 7 0.0215
15 REBOUND PSYCHOSIS 4 0.0188
16 AGITATED DEPRESSION 5 0.0174
17 KERATIC PRECIPITATES 8 0.0168
18 MACULAR DEGENERATION 199 0.0166
19 ANTICHOLINERGIC SYNDROME 23 0.0144
20 SEASONAL AFFECTIVE DISORDER 4 0.0126
21 EPIGLOTTIC OEDEMA 3 0.0114
22 INTERCOSTAL NEURALGIA 2 0.0112
23 FLAT ANTERIOR CHAMBER OF EYE 2 0.0112
24 DELUSION OF GRANDEUR 5 0.0111
25 CHOLINERGIC SYNDROME 7 0.0110
26 HYPHAEMA 5 0.0096
27 DELAYED RECOVERY FROM ANAESTHESIA 9 0.0095
28 HYPERTHERMIA MALIGNANT 14 0.0094
29 CHOROIDAL DETACHMENT 5 0.0090
30 MONOCYTE COUNT ABNORMAL 2 0.0090
31 CORNEAL EPITHELIUM DEFECT 5 0.0086
32 NEUROMUSCULAR BLOCK PROLONGED 3 0.0081
33 CORNEAL SCAR 4 0.0080
34 NECROTISING RETINITIS 5 0.0078
35 PRESSURE OF SPEECH 5 0.0077
36 FLIGHT OF IDEAS 4 0.0077
37 HYPOPYON 6 0.0072
38 HYPOTONY OF EYE 3 0.0071
39 CHONDROMALACIA 2 0.0070
40 ANTERIOR CHAMBER INFLAMMATION 4 0.0067
41 VAGINAL DISCHARGE 66 0.0065
42 ANOSOGNOSIA 5 0.0065
43 BRONCHIAL HAEMORRHAGE 2 0.0064
44 ANAPHYLACTOID SHOCK 3 0.0064
45 CORNEAL PERFORATION 4 0.0063
46 PARAESTHESIA ORAL 91 0.0063
47 LYMPHOCYTE STIMULATION TEST POSITIVE 5 0.0062
48 SCLERITIS 10 0.0062
49 IRIS ADHESIONS 3 0.0058
50 CORNEAL OEDEMA 13 0.0058
51 MYOGLOBINURIA 3 0.0056
52 VASOPLEGIA SYNDROME 9 0.0055
53 DRUG EFFECT PROLONGED 3 0.0054
54 MYCOBACTERIUM CHELONAE INFECTION 4 0.0054
55 PRODUCT PACKAGING CONFUSION 13 0.0053
56 BRONCHOPLEURAL FISTULA 2 0.0053
57 CARDIAC ASSISTANCE DEVICE USER 2 0.0053
58 ANISOCORIA 2 0.0053
59 NEUROBLASTOMA 2 0.0052
60 EYE INFECTION FUNGAL 2 0.0052
61 ORAL CANDIDIASIS 67 0.0051
62 CONSCIOUSNESS FLUCTUATING 5 0.0048
63 SPINAL CORD INJURY 8 0.0046
64 ANEURYSM RUPTURED 4 0.0044
65 ANTIBODY TEST ABNORMAL 3 0.0042
66 STRESS CARDIOMYOPATHY 24 0.0041
67 CREATININE RENAL CLEARANCE INCREASED 3 0.0040
68 INJURY CORNEAL 2 0.0038
69 COMA SCALE ABNORMAL 11 0.0038
70 HIRSUTISM 5 0.0038
71 SOMATIC SYMPTOM DISORDER 4 0.0037
72 BRONCHOSTENOSIS 2 0.0037
73 HYPERTENSIVE URGENCY 2 0.0036
74 SEROUS RETINAL DETACHMENT 3 0.0036
75 PERIORBITAL PAIN 3 0.0035
76 COMPARTMENT SYNDROME 9 0.0034
77 JUDGEMENT IMPAIRED 5 0.0034
78 AORTIC CALCIFICATION 2 0.0034
79 CONJUNCTIVAL HYPERAEMIA 12 0.0034
80 ANAESTHETIC COMPLICATION 9 0.0033
81 UPPER RESPIRATORY TRACT INFLAMMATION 4 0.0033
82 PUNCTATE KERATITIS 3 0.0033
83 INJECTION SITE ULCER 3 0.0032
84 ENDOPHTHALMITIS 19 0.0032
85 RED BLOOD CELLS URINE POSITIVE 3 0.0031
86 CHORIORETINITIS 2 0.0031
87 PROCEDURAL PAIN 85 0.0031
88 MYDRIASIS 39 0.0030
89 ARTERIOSPASM CORONARY 12 0.0030
90 CHOREA 5 0.0029
91 PUPIL FIXED 5 0.0029
92 SYSTOLIC DYSFUNCTION 3 0.0028
93 DELAYED GRAFT FUNCTION 2 0.0028
94 SCHIZOAFFECTIVE DISORDER 5 0.0028
95 BUNION 2 0.0028
96 POLYDIPSIA 11 0.0028
97 BACTERIAL DISEASE CARRIER 2 0.0027
98 CLONIC CONVULSION 2 0.0027
99 PULSE ABSENT 13 0.0027
100 ELECTROCARDIOGRAM ST SEGMENT ELEVATION 9 0.0027
101 PUPILLARY REFLEX IMPAIRED 5 0.0027
102 CORNEAL DEPOSITS 2 0.0027
103 MULTIPLE DRUG THERAPY 2 0.0027
104 THERAPEUTIC PRODUCT EFFECT DELAYED 12 0.0026
105 FREQUENT BOWEL MOVEMENTS 71 0.0026
106 SICK SINUS SYNDROME 3 0.0026
107 COAGULATION TEST ABNORMAL 2 0.0026
108 SENSE OF OPPRESSION 3 0.0025
109 CHOROIDAL EFFUSION 2 0.0025
110 ILEUS PARALYTIC 11 0.0025
111 BLOOD PRESSURE SYSTOLIC DECREASED 11 0.0024
112 TROPONIN I INCREASED 4 0.0024
113 DENTAL DISCOMFORT 2 0.0024
114 CORNEAL DISORDER 5 0.0023
115 BIPOLAR I DISORDER 5 0.0023
116 ELECTROCARDIOGRAM ST SEGMENT DEPRESSION 5 0.0023
117 CARDIAC OUTPUT DECREASED 2 0.0023
118 ANTIPSYCHOTIC DRUG LEVEL ABOVE THERAPEUTIC 2 0.0022
119 IRON DEFICIENCY 10 0.0022
120 MUCOSAL EROSION 2 0.0022
121 MUCOUS MEMBRANE DISORDER 3 0.0022
122 TENDON DISORDER 14 0.0021
123 HYPERVIGILANCE 2 0.0021
124 ATRIOVENTRICULAR BLOCK SECOND DEGREE 6 0.0020
125 COLITIS 74 0.0020
126 ELECTROCARDIOGRAM T WAVE ABNORMAL 3 0.0019
127 PULSELESS ELECTRICAL ACTIVITY 8 0.0019
128 SINUS ARREST 3 0.0019
129 RECTAL HAEMORRHAGE 82 0.0019
130 HYPOPERFUSION 2 0.0019
131 CHRONIC KIDNEY DISEASE-MINERAL AND BONE DISORDER 2 0.0019
132 COLON CANCER METASTATIC 3 0.0019
133 LARYNGOSPASM 5 0.0019
134 BLADDER DILATATION 2 0.0018
135 ULCERATIVE KERATITIS 5 0.0018
136 VITREOUS HAEMORRHAGE 5 0.0018
137 LYMPHOCYTE COUNT ABNORMAL 2 0.0018
138 VENTRICULAR TACHYCARDIA 29 0.0018
139 EXOSTOSIS 16 0.0018
140 BLOOD CHLORIDE INCREASED 3 0.0017
141 WOUND INFECTION STAPHYLOCOCCAL 3 0.0017
142 EPIDIDYMITIS 2 0.0017
143 ALLODYNIA 2 0.0017
144 AUTONOMIC NERVOUS SYSTEM IMBALANCE 5 0.0017
145 PARAPARESIS 3 0.0017
146 CARDIAC ABLATION 3 0.0017
147 SUPRAVENTRICULAR TACHYCARDIA 16 0.0017
148 MONOPARESIS 3 0.0017
149 ABSCESS LIMB 7 0.0016
150 HYPERPARATHYROIDISM SECONDARY 4 0.0016
151 BRADYCARDIA NEONATAL 2 0.0016
152 LIP DISCOLOURATION 2 0.0016
153 PROCEDURAL COMPLICATION 12 0.0016
154 BLOOD CHLORIDE DECREASED 4 0.0015
155 OCULAR HYPERTENSION 3 0.0015
156 APNOEA 12 0.0015
157 DRUG RASH WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 5 0.0015
158 CATATONIA 8 0.0015
159 COLITIS ULCERATIVE 68 0.0015
160 EMPYEMA 3 0.0015
161 MUCOSAL DRYNESS 3 0.0015
162 BRADYPNOEA 4 0.0015
163 EYELID PAIN 3 0.0015
164 CLUSTER HEADACHE 2 0.0015
165 ISCHAEMIC HEPATITIS 2 0.0015
166 QUADRIPLEGIA 3 0.0015
167 FOOT DEFORMITY 16 0.0014
168 VENTRICULAR FIBRILLATION 16 0.0014
169 N-TERMINAL PROHORMONE BRAIN NATRIURETIC PEPTIDE INCREASED 2 0.0014
170 DISSEMINATED INTRAVASCULAR COAGULATION 20 0.0014
171 RETINAL DETACHMENT 13 0.0014
172 HAEMATOCHEZIA 77 0.0014
173 MOUTH SWELLING 8 0.0014
174 TOXIC EPIDERMAL NECROLYSIS 21 0.0014
175 INFUSION RELATED REACTION 90 0.0014
176 ANAPHYLACTIC SHOCK 35 0.0014
177 THERAPEUTIC PRODUCT EFFECT INCOMPLETE 96 0.0013
178 ATRIOVENTRICULAR BLOCK COMPLETE 9 0.0013
179 CHOLANGIOCARCINOMA 2 0.0013
180 POLYURIA 11 0.0013
181 HYPERCAPNIA 4 0.0013
182 KOUNIS SYNDROME 3 0.0013
183 BODY TEMPERATURE DECREASED 13 0.0013
184 HYPERTHERMIA 10 0.0013
185 GENITAL HERPES 2 0.0013
186 LARGE INTESTINE PERFORATION 9 0.0013
187 OLIGURIA 8 0.0013
188 INHIBITORY DRUG INTERACTION 2 0.0013
189 CARDIOGENIC SHOCK 18 0.0013
190 VENTRICULAR HYPOKINESIA 4 0.0012
191 SUBSTANCE ABUSE 10 0.0012
192 HYPOVENTILATION 4 0.0012
193 BRADYARRHYTHMIA 2 0.0012
194 ILEUS 15 0.0012
195 MYOCARDIAL NECROSIS MARKER INCREASED 2 0.0012
196 BRADYCARDIA 63 0.0012
197 WRONG PRODUCT ADMINISTERED 8 0.0012
198 HYPERPYREXIA 5 0.0012
199 SEDATION COMPLICATION 3 0.0012
200 ANGLE CLOSURE GLAUCOMA 3 0.0012
201 CANCER PAIN 3 0.0012
202 GLIOBLASTOMA 2 0.0012
203 ANKLE FRACTURE 18 0.0012
204 CERVICAL SPINAL STENOSIS 2 0.0012
205 DROOLING 8 0.0012
206 INFUSION SITE DISCHARGE 2 0.0011
207 ATELECTASIS 11 0.0011
208 PRODUCT INEFFECTIVE FOR UNAPPROVED USE 3 0.0011
209 DRUG WITHDRAWAL CONVULSIONS 2 0.0011
210 PHOTOPHOBIA 21 0.0011
211 BEHAVIOUR DISORDER 6 0.0011
212 NEUROLEPTIC MALIGNANT SYNDROME 13 0.0011
213 METABOLIC ACIDOSIS 35 0.0011
214 CONDUCTION DISORDER 2 0.0011
215 MUSCLE RIGIDITY 13 0.0011
216 NEPHROGENIC ANAEMIA 5 0.0011
217 PROTEIN TOTAL DECREASED 4 0.0011
218 PANCREATIC CARCINOMA METASTATIC 3 0.0011
219 EYE PAIN 59 0.0010
220 LYMPHADENOPATHY MEDIASTINAL 2 0.0010
221 FIBULA FRACTURE 3 0.0010
222 DELUSION 16 0.0010
223 GASTROINTESTINAL NECROSIS 3 0.0010
224 CYTOMEGALOVIRUS CHORIORETINITIS 2 0.0010
225 HYPOVOLAEMIA 6 0.0010
226 STRABISMUS 3 0.0010
227 RESPIRATORY ACIDOSIS 4 0.0010
228 LUNG ADENOCARCINOMA 3 0.0010
229 MIOSIS 8 0.0010
230 DYSPEPSIA 97 0.0010
231 INJECTION SITE NECROSIS 2 0.0010
232 ANAPHYLACTOID REACTION 4 0.0010
233 DIASTOLIC DYSFUNCTION 3 0.0010
234 BLOOD CREATININE DECREASED 3 0.0010
235 NEUROGENIC BLADDER 2 0.0009
236 SINUS BRADYCARDIA 9 0.0009
237 AMYOTROPHIC LATERAL SCLEROSIS 2 0.0009
238 ATRIOVENTRICULAR BLOCK FIRST DEGREE 4 0.0009
239 ATRIOVENTRICULAR BLOCK 7 0.0009
240 ELECTROCARDIOGRAM T WAVE INVERSION 2 0.0009
241 WRONG DRUG ADMINISTERED 8 0.0009
242 RESPIRATORY DEPRESSION 11 0.0009
243 FOOT FRACTURE 17 0.0009
244 ACUTE PULMONARY OEDEMA 5 0.0009
245 BLOOD CALCIUM DECREASED 10 0.0009
246 SUPRAVENTRICULAR EXTRASYSTOLES 3 0.0009
247 RHABDOMYOLYSIS 37 0.0009
248 HEPATOCELLULAR DAMAGE 2 0.0009
249 CHRONIC GASTRITIS 2 0.0009
250 POST PROCEDURAL COMPLICATION 17 0.0009
251 CHOLECYSTITIS ACUTE 5 0.0009
252 CARDIOMYOPATHY 13 0.0009
253 BUNDLE BRANCH BLOCK RIGHT 4 0.0009
254 VENTRICULAR EXTRASYSTOLES 9 0.0009
255 HAEMOLYTIC URAEMIC SYNDROME 2 0.0009
256 RALES 5 0.0009
257 INFUSION SITE INFECTION 2 0.0009
258 PRODUCT LABEL CONFUSION 5 0.0009
259 BILIRUBIN CONJUGATED INCREASED 2 0.0009
260 INGROWING NAIL 2 0.0008
261 INTRA-ABDOMINAL HAEMORRHAGE 2 0.0008
262 LACUNAR INFARCTION 2 0.0008
263 SYNOVITIS 15 0.0008
264 HUMERUS FRACTURE 4 0.0008
265 LARYNGEAL OEDEMA 5 0.0008
266 DELIRIUM 28 0.0008
267 DEVICE INFUSION ISSUE 2 0.0008
268 HYPERNATRAEMIA 4 0.0008
269 PROTEIN URINE PRESENT 4 0.0008
270 MYOCARDIAL ISCHAEMIA 9 0.0008
271 TROPONIN INCREASED 6 0.0008
272 TONGUE OEDEMA 3 0.0008
273 SYSTEMIC INFLAMMATORY RESPONSE SYNDROME 3 0.0008
274 ENTERITIS 5 0.0008
275 PHLEBITIS 4 0.0008
276 PROCTALGIA 5 0.0008
277 AORTIC ARTERIOSCLEROSIS 2 0.0008
278 SINUS TACHYCARDIA 11 0.0008
279 BRONCHOSPASM 11 0.0008
280 PERIORBITAL OEDEMA 4 0.0008
281 CARDIO-RESPIRATORY ARREST 32 0.0008
282 PARTIAL SEIZURES 4 0.0008
283 HYPOXIC-ISCHAEMIC ENCEPHALOPATHY 2 0.0008
284 LUNG OPACITY 2 0.0008
285 CARDIAC ARREST 62 0.0008
286 ANAL FISTULA 4 0.0007
287 CREATININE RENAL CLEARANCE DECREASED 3 0.0007
288 LEFT VENTRICULAR DYSFUNCTION 5 0.0007
289 HYPERLACTACIDAEMIA 2 0.0007
290 BLOOD SODIUM INCREASED 2 0.0007
291 EYE INFLAMMATION 7 0.0007
292 CLONUS 2 0.0007
293 AORTIC DISSECTION 3 0.0007
294 BLOOD PRESSURE SYSTOLIC INCREASED 14 0.0007
295 HAEMODIALYSIS 6 0.0007
296 NEUTROPHIL COUNT ABNORMAL 2 0.0007
297 BUNDLE BRANCH BLOCK LEFT 3 0.0007
298 HYPERTONIA 4 0.0007
299 MYOPATHY 6 0.0007
300 BLOOD LACTATE DEHYDROGENASE INCREASED 11 0.0007
301 MULTI-ORGAN FAILURE 12 0.0007
302 PRODUCT ADMINISTRATION ERROR 14 0.0007
303 FEELING OF BODY TEMPERATURE CHANGE 4 0.0007
304 LYMPHOPROLIFERATIVE DISORDER 2 0.0007
305 BLOOD PRESSURE DECREASED 45 0.0007
306 EYE DISCHARGE 7 0.0007
307 HISTIOCYTOSIS HAEMATOPHAGIC 2 0.0007
308 DUODENAL ULCER PERFORATION 5 0.0007
309 THIRST 12 0.0007
310 CEREBROVASCULAR DISORDER 2 0.0007
311 CENTRAL VENOUS CATHETERISATION 2 0.0007
312 COAGULOPATHY 11 0.0007
313 EMBOLISM VENOUS 2 0.0007
314 KERATITIS 2 0.0007
315 IRITIS 2 0.0007
316 HAEMODYNAMIC INSTABILITY 5 0.0007
317 HAEMATOCRIT DECREASED 13 0.0007
318 MASTICATION DISORDER 2 0.0007
319 CHEST X-RAY ABNORMAL 2 0.0007
320 SHOCK 15 0.0007
321 INTRACARDIAC THROMBUS 2 0.0007
322 EYE OPERATION 3 0.0007
323 CARDIOMEGALY 8 0.0006
324 CIRCULATORY COLLAPSE 11 0.0006
325 SKIN LACERATION 7 0.0006
326 BRAIN OEDEMA 8 0.0006
327 IRIDOCYCLITIS 2 0.0006
328 MUSCLE ATROPHY 8 0.0006
329 BLOOD ALBUMIN DECREASED 5 0.0006
330 PARALYSIS 9 0.0006
331 PULMONARY OEDEMA 28 0.0006
332 OCULAR DISCOMFORT 7 0.0006
333 AFFECT LABILITY 6 0.0006
334 OBSESSIVE-COMPULSIVE DISORDER 5 0.0006
335 GUILLAIN-BARRE SYNDROME 3 0.0006
336 RHINITIS 5 0.0006
337 HALLUCINATION, VISUAL 13 0.0006
338 SHOCK HAEMORRHAGIC 5 0.0006
339 DECUBITUS ULCER 5 0.0006
340 CARDIAC FAILURE ACUTE 4 0.0006
341 SALIVARY HYPERSECRETION 6 0.0006
342 BLOOD UREA INCREASED 10 0.0006
343 IMPAIRED GASTRIC EMPTYING 8 0.0006
344 EUPHORIC MOOD 6 0.0006
345 ELECTROCARDIOGRAM QRS COMPLEX PROLONGED 3 0.0006
346 PERIPHERAL VASCULAR DISORDER 3 0.0006
347 SKIN ULCER 15 0.0006
348 URINARY RETENTION 19 0.0006
349 JAUNDICE CHOLESTATIC 2 0.0006
350 NYSTAGMUS 3 0.0006
351 PHARYNGOLARYNGEAL PAIN 3 0.0006
352 RETINAL HAEMORRHAGE 4 0.0006
353 INTERCEPTED PRODUCT STORAGE ERROR 2 0.0006
354 DYSARTHRIA 21 0.0006
355 GINGIVITIS 3 0.0006
356 BLOOD CREATINE PHOSPHOKINASE INCREASED 16 0.0006
357 VISUAL FIELD DEFECT 4 0.0006
358 FAECALOMA 3 0.0005
359 ANAEMIA 103 0.0005
360 TRANSAMINASES INCREASED 12 0.0005
361 OBSTRUCTIVE AIRWAYS DISORDER 6 0.0005
362 HYPERACUSIS 2 0.0005
363 EYE INFECTION 6 0.0005
364 ABORTION INDUCED 5 0.0005
365 DEPRESSED LEVEL OF CONSCIOUSNESS 21 0.0005
366 ERYTHEMA 109 0.0005
367 POISONING DELIBERATE 5 0.0005
368 CONSTIPATION 115 0.0005
369 CONJUNCTIVAL HAEMORRHAGE 2 0.0005
370 ACIDOSIS 4 0.0005
371 ELECTROLYTE IMBALANCE 6 0.0005
372 TACHYPNOEA 7 0.0005
373 SYRINGE ISSUE 9 0.0005
374 VITAMIN D DEFICIENCY 5 0.0005
375 TORSADE DE POINTES 4 0.0005
376 CYANOSIS 8 0.0005
377 PSYCHOTIC DISORDER 15 0.0005
378 RESPIRATORY DISTRESS 14 0.0005
379 ATAXIA 6 0.0005
380 CATARACT OPERATION 3 0.0005
381 PRODUCT DISPENSING ERROR 11 0.0005
382 AGITATION 37 0.0005
383 CEREBRAL ATROPHY 2 0.0005
384 PROTHROMBIN TIME PROLONGED 3 0.0005
385 HYPOTONIA 5 0.0005
386 FRUSTRATION TOLERANCE DECREASED 4 0.0005
387 SCHIZOPHRENIA 6 0.0005
388 ABNORMAL FAECES 4 0.0005
389 HYPERAESTHESIA 4 0.0005
390 EXTRAPYRAMIDAL DISORDER 12 0.0005
391 MUSCLE INJURY 4 0.0005
392 VISUAL ACUITY REDUCED 16 0.0005
393 WEIGHT FLUCTUATION 5 0.0005
394 LIP OEDEMA 2 0.0005
395 FEELING JITTERY 9 0.0005
396 FOREIGN BODY SENSATION IN EYES 3 0.0005
397 INTRAOCULAR PRESSURE INCREASED 6 0.0005
398 CHOLESTASIS 9 0.0005
399 INCORRECT ROUTE OF PRODUCT ADMINISTRATION 8 0.0005
400 BLOOD POTASSIUM DECREASED 14 0.0005
401 PYREXIA 161 0.0005
402 ANURIA 4 0.0005
403 METASTATIC NEOPLASM 2 0.0005
404 TACHYCARDIA 41 0.0005
405 URINE OUTPUT DECREASED 4 0.0005
406 DIVERTICULUM INTESTINAL 2 0.0005
407 ASPIRATION 5 0.0005
408 SPINAL OSTEOARTHRITIS 4 0.0005
409 METASTASES TO LIVER 8 0.0005
410 PHARYNGEAL OEDEMA 7 0.0005
411 ABDOMINAL ABSCESS 2 0.0005
412 CEREBRAL INFARCTION 11 0.0004
413 HYPERTENSIVE CRISIS 5 0.0004
414 SKIN MASS 3 0.0004
415 CARDIOTOXICITY 4 0.0004
416 OSTEOARTHRITIS 19 0.0004
417 MALNUTRITION 5 0.0004
418 METASTASES TO LYMPH NODES 3 0.0004
419 OCULAR HYPERAEMIA 21 0.0004
420 BODY TEMPERATURE INCREASED 9 0.0004
421 PNEUMONIA ASPIRATION 11 0.0004
422 END STAGE RENAL DISEASE 8 0.0004
423 ABDOMINAL PAIN 102 0.0004
424 NEPHROTIC SYNDROME 3 0.0004
425 DRUG LEVEL ABOVE THERAPEUTIC 2 0.0004
426 RESPIRATORY ARREST 12 0.0004
427 NEOPLASM 5 0.0004
428 LARGE INTESTINE POLYP 3 0.0004
429 BLOOD POTASSIUM INCREASED 7 0.0004
430 EYELID OEDEMA 5 0.0004
431 EXTRASYSTOLES 3 0.0004
432 HEPATIC FUNCTION ABNORMAL 16 0.0004
433 HEART RATE DECREASED 15 0.0004
434 TOXICITY TO VARIOUS AGENTS 72 0.0004
435 HYPOXIA 15 0.0004
436 BLINDNESS UNILATERAL 6 0.0004
437 WEIGHT DECREASED 118 0.0004
438 BLOOD URINE PRESENT 8 0.0004
439 CARDIAC TAMPONADE 2 0.0004
440 HYPOVOLAEMIC SHOCK 2 0.0004
441 FAECAL INCONTINENCE 2 0.0004
442 GASTROINTESTINAL TOXICITY 2 0.0004
443 SWOLLEN TONGUE 13 0.0004
444 GLAUCOMA 8 0.0004
445 NASAL POLYPS 2 0.0004
446 PARANOIA 7 0.0004
447 HYPERVOLAEMIA 2 0.0004
448 MUCOUS STOOLS 2 0.0004
449 HYPOTENSION 81 0.0004
450 EYE SWELLING 15 0.0004
451 PULMONARY MASS 6 0.0004
452 ABDOMINAL TENDERNESS 2 0.0004
453 ORTHOSTATIC HYPOTENSION 7 0.0004
454 FLUID INTAKE REDUCED 2 0.0004
455 HYPERKALAEMIA 14 0.0004
456 CORONARY ARTERY STENOSIS 2 0.0004
457 LYMPHOCYTE COUNT DECREASED 7 0.0004
458 MEDICATION ERROR 22 0.0004
459 ACUTE RESPIRATORY DISTRESS SYNDROME 7 0.0004
460 KLEBSIELLA INFECTION 2 0.0004
461 ASPARTATE AMINOTRANSFERASE INCREASED 21 0.0004
462 DYSPHORIA 2 0.0004
463 PSORIATIC ARTHROPATHY 16 0.0004
464 SUBARACHNOID HAEMORRHAGE 4 0.0004
465 RENAL FAILURE CHRONIC 3 0.0004
466 LOW DENSITY LIPOPROTEIN INCREASED 3 0.0004
467 LUNG INFECTION 6 0.0004
468 HAEMATOMA 10 0.0004
469 FAILURE TO THRIVE 2 0.0004
470 HALLUCINATION 29 0.0004
471 POLLAKIURIA 16 0.0004
472 PULMONARY HAEMORRHAGE 3 0.0004
473 NEEDLE ISSUE 11 0.0004
474 RENAL CYST 3 0.0004
475 ACUTE KIDNEY INJURY 57 0.0004
476 MYASTHENIA GRAVIS 3 0.0004
477 ANAL ABSCESS 2 0.0004
478 BLOOD BILIRUBIN INCREASED 10 0.0004
479 NEURALGIA 9 0.0004
480 ERYTHEMA OF EYELID 2 0.0004
481 BLINDNESS 15 0.0004
482 VISION BLURRED 50 0.0004
483 UPPER-AIRWAY COUGH SYNDROME 3 0.0004
484 ACUTE RESPIRATORY FAILURE 7 0.0004
485 GENERALISED TONIC-CLONIC SEIZURE 6 0.0004
486 BLOOD ALKALINE PHOSPHATASE INCREASED 9 0.0004
487 ERUCTATION 7 0.0004
488 EAR PAIN 7 0.0004
489 ALANINE AMINOTRANSFERASE INCREASED 22 0.0004
490 TYPE 2 DIABETES MELLITUS 12 0.0004
491 GENERALISED ERYTHEMA 2 0.0004
492 GRANULOCYTOPENIA 2 0.0004
493 PSEUDOMONAS INFECTION 3 0.0003
494 MYOCARDITIS 4 0.0003
495 BLOOD MAGNESIUM DECREASED 3 0.0003
496 HYPOKALAEMIA 16 0.0003
497 ENTEROCOLITIS 2 0.0003
498 HYSTERECTOMY 3 0.0003
499 SEDATION 9 0.0003
500 NEUTROPHIL COUNT DECREASED 14 0.0003
501 MOVEMENT DISORDER 11 0.0003
502 WHITE BLOOD CELL COUNT INCREASED 13 0.0003
503 OXYGEN SATURATION DECREASED 19 0.0003
504 CARDIAC PACEMAKER INSERTION 2 0.0003
505 MYOCLONUS 4 0.0003
506 HYPERLIPIDAEMIA 4 0.0003
507 HEPATITIS CHOLESTATIC 2 0.0003
508 LACRIMATION INCREASED 10 0.0003
509 RENAL FAILURE ACUTE 14 0.0003
510 DERMATITIS ACNEIFORM 2 0.0003
511 ACCIDENTAL OVERDOSE 12 0.0003
512 SMALL INTESTINAL OBSTRUCTION 4 0.0003
513 HYPERCALCAEMIA 4 0.0003
514 ALTERED STATE OF CONSCIOUSNESS 7 0.0003
515 CHOLANGITIS 2 0.0003
516 CYST 4 0.0003
517 DIARRHOEA HAEMORRHAGIC 3 0.0003
518 CLOSTRIDIUM DIFFICILE INFECTION 7 0.0003
519 THERAPY PARTIAL RESPONDER 5 0.0003
520 LACERATION 3 0.0003
521 INFUSION SITE SWELLING 2 0.0003
522 CHRONIC KIDNEY DISEASE 24 0.0003
523 RESPIRATORY FAILURE 23 0.0003
524 PNEUMOTHORAX 5 0.0003
525 RED BLOOD CELL COUNT DECREASED 9 0.0003
526 EYE IRRITATION 18 0.0003
527 INCOHERENT 2 0.0003
528 MOBILITY DECREASED 22 0.0003
529 RENAL TUBULAR NECROSIS 3 0.0003
530 VITREOUS FLOATERS 3 0.0003
531 NEUROPATHY PERIPHERAL 29 0.0003
532 MANIA 5 0.0003
533 DYSGRAPHIA 2 0.0003
534 ARTERIOSCLEROSIS CORONARY ARTERY 2 0.0003
535 MALAISE 132 0.0003
536 RESTLESSNESS 11 0.0003
537 PNEUMOCYSTIS JIROVECII PNEUMONIA 3 0.0003
538 CHOLECYSTITIS CHRONIC 2 0.0003
539 SEPTIC SHOCK 13 0.0003
540 EMPHYSEMA 3 0.0003
541 UPPER GASTROINTESTINAL HAEMORRHAGE 5 0.0003
542 BRONCHIECTASIS 2 0.0003
543 HYPOTHERMIA 3 0.0003
544 HEMIPARESIS 5 0.0003
545 GENERAL PHYSICAL CONDITION ABNORMAL 2 0.0003
546 MOTOR DYSFUNCTION 3 0.0003
547 NEUTROPHIL COUNT INCREASED 3 0.0003
548 ECCHYMOSIS 2 0.0003
549 PERITONITIS 6 0.0003
550 TENDERNESS 3 0.0003
551 HYPOMAGNESAEMIA 4 0.0003
552 PANCYTOPENIA 16 0.0003
553 RENAL FAILURE 38 0.0003
554 SEIZURE 33 0.0003
555 DEFAECATION URGENCY 2 0.0003
556 DEVICE OCCLUSION 4 0.0003
557 HYPONATRAEMIA 16 0.0003
558 DRUG INTERACTION 45 0.0003
559 SUDDEN DEATH 3 0.0003
560 HAND FRACTURE 2 0.0003
561 DRUG ERUPTION 5 0.0003
562 DIVERTICULUM 2 0.0003
563 NEUTROPENIC SEPSIS 2 0.0003
564 HYPERSOMNIA 8 0.0003
565 GRAFT VERSUS HOST DISEASE 2 0.0003
566 LACTIC ACIDOSIS 9 0.0003
567 LEUKOCYTOSIS 5 0.0003
568 TOOTHACHE 5 0.0003
569 ARRHYTHMIA 13 0.0003
570 APATHY 4 0.0003
571 GASTROENTERITIS 4 0.0003
572 HYPOPHAGIA 7 0.0003
573 MAJOR DEPRESSION 2 0.0003
574 MOUTH HAEMORRHAGE 2 0.0003
575 MELAENA 6 0.0003
576 CONFUSIONAL STATE 44 0.0003
577 DRUG REACTION WITH EOSINOPHILIA AND SYSTEMIC SYMPTOMS 7 0.0003
578 FEBRILE NEUTROPENIA 18 0.0003
579 LOWER GASTROINTESTINAL HAEMORRHAGE 2 0.0003
580 STEVENS-JOHNSON SYNDROME 6 0.0003
581 EYE PRURITUS 9 0.0003
582 THERAPY NON-RESPONDER 12 0.0003
583 CHROMATURIA 6 0.0003
584 HYPERHIDROSIS 34 0.0003
585 GASTRIC ULCER 5 0.0003
586 AORTIC ANEURYSM 2 0.0003
587 MICTURITION URGENCY 3 0.0003
588 DRUG DISPENSING ERROR 4 0.0003
589 DEVICE RELATED INFECTION 4 0.0003
590 MUSCULOSKELETAL CHEST PAIN 4 0.0003
591 ACUTE GENERALISED EXANTHEMATOUS PUSTULOSIS 2 0.0003
592 PALLOR 7 0.0003
593 ATRIAL FIBRILLATION 25 0.0003
594 FLUSHING 26 0.0003
595 ARTERIAL OCCLUSIVE DISEASE 2 0.0003
596 AFFECTIVE DISORDER 2 0.0003
597 COVID-19 PNEUMONIA 3 0.0003
598 ANAPHYLACTIC REACTION 14 0.0003
599 INCORRECT ROUTE OF DRUG ADMINISTRATION 9 0.0003
600 CYSTITIS 8 0.0003
601 ABSCESS 4 0.0003
602 WRIST FRACTURE 3 0.0003
603 SPEECH DISORDER 13 0.0002
604 MENTAL IMPAIRMENT 6 0.0002
605 NO THERAPEUTIC RESPONSE 3 0.0002
606 BLOOD CREATININE INCREASED 16 0.0002
607 ENCEPHALOPATHY 6 0.0002
608 METASTASES TO BONE 4 0.0002
609 HEART RATE INCREASED 24 0.0002
610 GENERAL PHYSICAL HEALTH DETERIORATION 28 0.0002
611 DRUG LEVEL INCREASED 4 0.0002
612 ACUTE CORONARY SYNDROME 2 0.0002
613 NAUSEA 191 0.0002
614 PSYCHOMOTOR HYPERACTIVITY 4 0.0002
615 EMBOLISM 2 0.0002
616 OFF LABEL USE 210 0.0002
617 POISONING 3 0.0002
618 DERMATITIS 5 0.0002
619 DRUG INEFFECTIVE 314 0.0002
620 MUSCULAR WEAKNESS 27 0.0002
621 ACUTE MYOCARDIAL INFARCTION 7 0.0002
622 RETCHING 5 0.0002
623 HAEMOGLOBIN DECREASED 24 0.0002
624 HAEMATURIA 8 0.0002
625 ROTATOR CUFF SYNDROME 3 0.0002
626 INFUSION SITE PAIN 3 0.0002
627 APHASIA 7 0.0002
628 COMA 11 0.0002
629 PLEURAL EFFUSION 14 0.0002
630 DIARRHOEA 148 0.0002
631 URINARY TRACT INFECTION 39 0.0002
632 CONVULSION 13 0.0002
633 LUNG INFILTRATION 2 0.0002
634 LIVER DISORDER 10 0.0002
635 FACIAL PAIN 2 0.0002
636 HAEMOLYTIC ANAEMIA 2 0.0002
637 JAUNDICE 6 0.0002
638 PAIN 136 0.0002
639 OEDEMA 12 0.0002
640 VOMITING 104 0.0002
641 UVEITIS 3 0.0002
642 BALANCE DISORDER 19 0.0002
643 PERIPHERAL COLDNESS 3 0.0002
644 CATARACT 13 0.0002
645 BRAIN NEOPLASM 2 0.0002
646 DEHYDRATION 29 0.0002
647 IRON DEFICIENCY ANAEMIA 2 0.0002
648 INTERVERTEBRAL DISC DEGENERATION 2 0.0002
649 ARTHRITIS 17 0.0002
650 DEMENTIA 6 0.0002
651 ERYTHEMA MULTIFORME 2 0.0002
652 BACTERIAL INFECTION 4 0.0002
653 NEPHROPATHY 2 0.0002
654 SLEEP DISORDER 15 0.0002
655 BLOOD SODIUM DECREASED 4 0.0002
656 MULTIPLE ORGAN DYSFUNCTION SYNDROME 6 0.0002
657 SYNCOPE 21 0.0002
658 ANGINA PECTORIS 6 0.0002
659 PULMONARY FIBROSIS 4 0.0002
660 HYPERTENSION 44 0.0002
661 TRANSIENT ISCHAEMIC ATTACK 7 0.0002
662 ANGER 7 0.0002
663 DECREASED APPETITE 48 0.0002
664 HYPOKINESIA 3 0.0002
665 COMPLICATION ASSOCIATED WITH DEVICE 3 0.0002
666 HEADACHE 129 0.0002
667 HEPATOMEGALY 2 0.0002
668 COLON CANCER 3 0.0002
669 DEEP VEIN THROMBOSIS 13 0.0002
670 BRAIN INJURY 2 0.0002
671 HEPATIC FAILURE 6 0.0002
672 HYPOAESTHESIA ORAL 3 0.0002
673 SOMNOLENCE 40 0.0002
674 CELLULITIS 10 0.0002
675 ABDOMINAL PAIN LOWER 5 0.0002
676 HAEMATEMESIS 5 0.0002
677 DEVICE BREAKAGE 8 0.0002
678 DEVICE FAILURE 3 0.0002
679 DYSKINESIA 8 0.0002
680 EYELID PTOSIS 2 0.0002
681 LOSS OF CONSCIOUSNESS 25 0.0002
682 INAPPROPRIATE ANTIDIURETIC HORMONE SECRETION 2 0.0002
683 LUNG NEOPLASM MALIGNANT 8 0.0002
684 RIB FRACTURE 4 0.0002
685 DISEASE PROGRESSION 23 0.0002
686 TENDONITIS 3 0.0002
687 UNRESPONSIVE TO STIMULI 5 0.0002
688 EJECTION FRACTION DECREASED 3 0.0002
689 COGNITIVE DISORDER 9 0.0002
690 PHARMACEUTICAL PRODUCT COMPLAINT 5 0.0002
691 FALL 64 0.0002
692 MOUTH ULCERATION 4 0.0002
693 ASTHENIA 71 0.0002
694 HALLUCINATION, AUDITORY 3 0.0002
695 SEPSIS 21 0.0002
696 EAR INFECTION 5 0.0002
697 PLATELET COUNT DECREASED 20 0.0002
698 VISUAL IMPAIRMENT 23 0.0002
699 OVERDOSE 40 0.0002
700 LUNG DISORDER 9 0.0002
701 IRRITABILITY 11 0.0002
702 OSTEONECROSIS 6 0.0002
703 CYTOMEGALOVIRUS INFECTION 3 0.0002
704 MENTAL STATUS CHANGES 5 0.0002
705 LEUKOPENIA 9 0.0002
706 NERVE INJURY 2 0.0002
707 RASH MACULO-PAPULAR 4 0.0002
708 HEPATOTOXICITY 4 0.0002
709 FEELING COLD 5 0.0002
710 GAIT INABILITY 6 0.0002
711 HAEMOPTYSIS 5 0.0002
712 DYSPHAGIA 17 0.0002
713 NECK PAIN 10 0.0002
714 PULMONARY EMBOLISM 17 0.0002
715 RENAL IMPAIRMENT 15 0.0002
716 FACE OEDEMA 3 0.0002
717 PRODUCT DOSE OMISSION IN ERROR 5 0.0002
718 INTERNATIONAL NORMALISED RATIO INCREASED 5 0.0002
719 WHITE BLOOD CELL COUNT DECREASED 19 0.0002
720 CHOLECYSTECTOMY 2 0.0002
721 METASTASES TO LUNG 2 0.0002
722 DEVICE DEFECTIVE 3 0.0002
723 DRY MOUTH 14 0.0002
724 NEOPLASM PROGRESSION 6 0.0002
725 CHRONIC OBSTRUCTIVE PULMONARY DISEASE 9 0.0002
726 MADAROSIS 2 0.0002
727 DEVICE USE ISSUE 3 0.0002
728 EOSINOPHILIA 3 0.0002
729 OSTEOPOROSIS 7 0.0002
730 LABORATORY TEST ABNORMAL 5 0.0002
731 AMNESIA 11 0.0002
732 SWELLING FACE 11 0.0002
733 WHEEZING 10 0.0002
734 BLOOD IRON DECREASED 2 0.0002
735 RENAL INJURY 5 0.0002
736 CHOLECYSTITIS 2 0.0002
737 BLOOD PRESSURE FLUCTUATION 4 0.0002
738 BURSITIS 2 0.0002
739 HYPERGLYCAEMIA 6 0.0002
740 PRESYNCOPE 4 0.0002
741 ABDOMINAL DISTENSION 17 0.0002
742 MUSCLE SPASTICITY 2 0.0002
743 CARDIAC FAILURE 13 0.0002
744 CONJUNCTIVITIS 3 0.0002
745 HEPATIC STEATOSIS 3 0.0002
746 THROMBOCYTOPENIA 18 0.0002
747 NERVOUS SYSTEM DISORDER 5 0.0002
748 DERMATITIS ALLERGIC 2 0.0002
749 PROTEINURIA 3 0.0002
750 CARDIOVASCULAR DISORDER 4 0.0002
751 SLEEP APNOEA SYNDROME 3 0.0002
752 INTENTIONAL OVERDOSE 10 0.0002
753 GASTROINTESTINAL HAEMORRHAGE 13 0.0002
754 METASTASES TO CENTRAL NERVOUS SYSTEM 2 0.0002
755 PRESCRIBED OVERDOSE 3 0.0002
756 DYSTONIA 3 0.0002
757 CONDITION AGGRAVATED 47 0.0002
758 NEUTROPENIA 21 0.0002
759 CHOKING 3 0.0002
760 NEPHROLITHIASIS 7 0.0002
761 CHOLELITHIASIS 5 0.0002
762 IMPAIRED HEALING 5 0.0002
763 ANHEDONIA 4 0.0002
764 BEDRIDDEN 2 0.0002
765 SINUS DISORDER 3 0.0002
766 PNEUMONIA 49 0.0002
767 BLOOD PRESSURE ABNORMAL 3 0.0002
768 LIP SWELLING 5 0.0001
769 SKIN DISORDER 5 0.0001
770 EYE HAEMORRHAGE 2 0.0001
771 THROMBOSIS 12 0.0001
772 CIRCUMSTANCE OR INFORMATION CAPABLE OF LEADING TO MEDICATION ERROR 5 0.0001
773 BONE MARROW FAILURE 3 0.0001
774 AKATHISIA 2 0.0001
775 CONTUSION 14 0.0001
776 TOOTH LOSS 3 0.0001
777 DRUG ABUSE 12 0.0001
778 ROAD TRAFFIC ACCIDENT 6 0.0001
779 BLISTER 8 0.0001
780 LYMPHADENOPATHY 5 0.0001
781 PAIN IN JAW 4 0.0001
782 DRY EYE 7 0.0001
783 PARAESTHESIA 22 0.0001
784 CEREBRAL HAEMORRHAGE 5 0.0001
785 SKIN CANCER 3 0.0001
786 IMPAIRED QUALITY OF LIFE 2 0.0001
787 HYPERTHYROIDISM 2 0.0001
788 NO ADVERSE EVENT 25 0.0001
789 MENTAL DISORDER 6 0.0001
790 BLOOD PRESSURE INCREASED 21 0.0001
791 DYSSTASIA 4 0.0001
792 DEATH 118 0.0001
793 MALIGNANT NEOPLASM PROGRESSION 14 0.0001
794 ASCITES 4 0.0001
795 PRODUCT DOSE OMISSION ISSUE 40 0.0001
796 DYSURIA 5 0.0001
797 GAMMA-GLUTAMYLTRANSFERASE INCREASED 3 0.0001
798 URINARY INCONTINENCE 4 0.0001
799 TOOTH DISORDER 3 0.0001
800 DEVICE ISSUE 12 0.0001
801 HAEMORRHAGE INTRACRANIAL 2 0.0001
802 RESPIRATORY DISORDER 4 0.0001
803 DYSPNOEA EXERTIONAL 5 0.0001
804 INTESTINAL OBSTRUCTION 5 0.0001
805 JOINT SWELLING 16 0.0001
806 COMPLETED SUICIDE 11 0.0001
807 ECONOMIC PROBLEM 2 0.0001
808 ILL-DEFINED DISORDER 8 0.0001
809 HIP ARTHROPLASTY 2 0.0001
810 UPPER RESPIRATORY TRACT INFECTION 6 0.0001
811 LYMPHOMA 2 0.0001
812 LIMB DISCOMFORT 4 0.0001
813 PLASMA CELL MYELOMA 5 0.0001
814 CHILLS 15 0.0001
815 ABNORMAL BEHAVIOUR 5 0.0001
816 DISORIENTATION 5 0.0001
817 GASTROOESOPHAGEAL REFLUX DISEASE 10 0.0001
818 INTERSTITIAL LUNG DISEASE 6 0.0001
819 HYPERSENSITIVITY 23 0.0001
820 OEDEMA PERIPHERAL 15 0.0001
821 ANXIETY 35 0.0001
822 GASTROINTESTINAL DISORDER 11 0.0001
823 ABASIA 3 0.0001
824 STAPHYLOCOCCAL INFECTION 4 0.0001
825 COUGH 34 0.0001
826 EXPIRED PRODUCT ADMINISTERED 4 0.0001
827 AGGRESSION 6 0.0001
828 CANDIDA INFECTION 2 0.0001
829 DIABETES MELLITUS 9 0.0001
830 FLUID RETENTION 6 0.0001
831 INFECTION 17 0.0001
832 SINUSITIS 12 0.0001
833 MEMORY IMPAIRMENT 16 0.0001
834 RESPIRATORY TRACT INFECTION 3 0.0001
835 DISCOMFORT 7 0.0001
836 MUCOSAL INFLAMMATION 3 0.0001
837 MUSCLE SPASMS 21 0.0001
838 GASTRITIS 3 0.0001
839 COLD SWEAT 2 0.0001
840 CHEST PAIN 21 0.0001
841 PRODUCT USE IN UNAPPROVED INDICATION 28 0.0001
842 DIABETES MELLITUS INADEQUATE CONTROL 2 0.0001
843 MATERNAL EXPOSURE DURING PREGNANCY 10 0.0001
844 THROAT IRRITATION 5 0.0001
845 THROAT TIGHTNESS 3 0.0001
846 GASTROENTERITIS VIRAL 2 0.0001
847 C-REACTIVE PROTEIN INCREASED 4 0.0001
848 BONE DISORDER 2 0.0001
849 ABNORMAL DREAMS 3 0.0001
850 BRONCHITIS 8 0.0001
851 DYSPNOEA 61 0.0001
852 WOUND 3 0.0001
853 EPISTAXIS 8 0.0001
854 FATIGUE 83 0.0001
855 FLATULENCE 6 0.0001
856 HYPOCALCAEMIA 2 0.0001
857 HERPES ZOSTER 6 0.0001
858 HYPOGLYCAEMIA 5 0.0001
859 INTENTIONAL PRODUCT MISUSE 9 0.0001
860 DYSPHONIA 6 0.0001
861 KIDNEY INFECTION 2 0.0001
862 COMPLICATION OF DEVICE INSERTION 2 0.0001
863 HYPOAESTHESIA 15 0.0001
864 CYTOKINE RELEASE SYNDROME 2 0.0001
865 FULL BLOOD COUNT DECREASED 2 0.0001
866 INAPPROPRIATE SCHEDULE OF DRUG ADMINISTRATION 7 0.0001
867 THERAPY INTERRUPTED 7 0.0001
868 DRUG ADMINISTRATION ERROR 3 0.0001
869 CHEST DISCOMFORT 10 0.0001
870 ILLNESS 10 0.0001
871 FEMUR FRACTURE 3 0.0001
872 TREMOR 16 0.0001
873 HEAD INJURY 3 0.0001
874 PANCREATITIS 5 0.0001
875 RASH 41 0.0001
876 GAIT DISTURBANCE 18 0.0001
877 EATING DISORDER 2 0.0001
878 JOINT INJURY 2 0.0001
879 HIP FRACTURE 3 0.0001
880 DISTURBANCE IN ATTENTION 5 0.0001
881 UNEVALUABLE EVENT 7 0.0001
882 DEPRESSION 21 0.0001
883 ABDOMINAL PAIN UPPER 19 0.0001
884 PAIN IN EXTREMITY 27 0.0001
885 DRUG INEFFECTIVE FOR UNAPPROVED INDICATION 5 0.0001
886 BACK PAIN 21 0.0001
887 VIRAL INFECTION 3 0.0001
888 FUNGAL INFECTION 3 0.0001
889 DRY SKIN 12 0.0001
890 ADVERSE DRUG REACTION 8 0.0001
891 HEART RATE IRREGULAR 2 0.0001
892 DRUG EXPOSURE DURING PREGNANCY 3 0.0001
893 MUSCLE TWITCHING 2 0.0001
894 NIGHTMARE 3 0.0001
895 OROPHARYNGEAL PAIN 8 0.0001
896 INSOMNIA 23 0.0001
897 HAEMORRHAGE 9 0.0001
898 SWELLING 8 0.0001
899 HOSPITALISATION 13 0.0001
900 PERIPHERAL SWELLING 13 0.0001
901 ELECTROCARDIOGRAM QT PROLONGED 3 0.0001
902 MYELOSUPPRESSION 3 0.0001
903 DIABETIC KETOACIDOSIS 2 0.0001
904 LOCALISED INFECTION 2 0.0001
905 FIBROMYALGIA 2 0.0001
906 DIZZINESS 41 0.0001
907 FEELING HOT 5 0.0001
908 ALOPECIA 16 0.0001
909 PRODUCT QUALITY ISSUE 11 0.0001
910 GLYCOSYLATED HAEMOGLOBIN INCREASED 2 0.0001
911 INAPPROPRIATE SCHEDULE OF PRODUCT ADMINISTRATION 14 0.0001
912 RHINORRHOEA 5 0.0001
913 DIPLOPIA 2 0.0001
914 MUSCULOSKELETAL PAIN 4 0.0001
915 JOINT STIFFNESS 2 0.0001
916 PRURITUS 29 0.0001
917 CARDIAC FAILURE CONGESTIVE 6 0.0001
918 MYOCARDIAL INFARCTION 13 0.0001
919 EMOTIONAL DISTRESS 9 0.0001
920 COVID-19 13 0.0001
921 LIMB INJURY 2 0.0001
922 MIGRAINE 7 0.0001
923 DEVICE DELIVERY SYSTEM ISSUE 2 0.0001
924 URTICARIA 12 0.0001
925 INJURY 5 0.0001
926 CEREBROVASCULAR ACCIDENT 12 0.0001
927 HYPOACUSIS 3 0.0001
928 LETHARGY 4 0.0001
929 LIVER FUNCTION TEST ABNORMAL 2 0.0001
930 MUSCULOSKELETAL STIFFNESS 6 0.0001
931 PALPITATIONS 8 0.0001
932 BONE PAIN 4 0.0001
933 ARTHRALGIA 28 0.0001
934 DYSGEUSIA 5 0.0001
935 THERAPEUTIC PRODUCT EFFECT DECREASED 3 0.0001
936 HOT FLUSH 5 0.0001
937 CONTRAINDICATED PRODUCT ADMINISTERED 2 0.0001
938 CORONARY ARTERY DISEASE 2 0.0001
939 STOMATITIS 4 0.0001
940 VERTIGO 4 0.0001
941 RENAL DISORDER 3 0.0001
942 WRONG TECHNIQUE IN PRODUCT USAGE PROCESS 13 0.0001
943 BONE DENSITY DECREASED 2 0.0001
944 DRUG-INDUCED LIVER INJURY 2 0.0001
945 BLOOD GLUCOSE INCREASED 12 0.0001
946 COLORECTAL CANCER 3 0.0001
947 PRODUCTIVE COUGH 3 0.0001
948 RASH ERYTHEMATOUS 3 0.0001
949 HYPOTHYROIDISM 2 0.0001
950 BLOOD GLUCOSE DECREASED 3 0.0001
951 DRUG INTOLERANCE 6 0.0001
952 ASTHMA 7 0.0001
953 INFLUENZA LIKE ILLNESS 5 0.0001
954 ABDOMINAL DISCOMFORT 10 0.0001
955 HEPATIC ENZYME INCREASED 4 0.0001
956 INFLAMMATION 3 0.0001
957 DEVICE USE ERROR 2 0.0001
958 BURNING SENSATION 4 0.0001
959 INCORRECT DOSE ADMINISTERED 13 0.0001
960 DERMATITIS ATOPIC 3 0.0001
961 CRYING 2 0.0001
962 TREATMENT NONCOMPLIANCE 3 0.0001
963 PRODUCT USE ISSUE 10 0.0001
964 SURGERY 3 0.0001
965 SUICIDE ATTEMPT 3 0.0000
966 EXPOSURE DURING PREGNANCY 3 0.0000
967 DEVICE DISLOCATION 2 0.0000
968 PRODUCT DOSE OMISSION 3 0.0000
969 INTENTIONAL PRODUCT USE ISSUE 4 0.0000
970 LOWER RESPIRATORY TRACT INFECTION 2 0.0000
971 ADVERSE EVENT 4 0.0000
972 BLOOD CHOLESTEROL INCREASED 2 0.0000
973 CARDIAC DISORDER 4 0.0000
974 DEVICE MALFUNCTION 3 0.0000
975 DISEASE RECURRENCE 2 0.0000
976 UNDERDOSE 3 0.0000
977 ACCIDENTAL EXPOSURE TO PRODUCT 4 0.0000
978 NASOPHARYNGITIS 7 0.0000
979 FOETAL EXPOSURE DURING PREGNANCY 3 0.0000
980 INFLUENZA 4 0.0000
981 WEIGHT INCREASED 8 0.0000
982 SKIN EXFOLIATION 3 0.0000
983 RHEUMATOID ARTHRITIS 4 0.0000
984 NASAL CONGESTION 2 0.0000
985 DEVICE DIFFICULT TO USE 2 0.0000
986 NEOPLASM MALIGNANT 2 0.0000
987 INJECTION SITE SWELLING 2 0.0000
988 BREAST CANCER 2 0.0000
989 FEELING ABNORMAL 5 0.0000
990 MYALGIA 3 0.0000
991 INJECTION SITE PAIN 5 0.0000
992 INJECTION SITE ERYTHEMA 2 0.0000